Kenji Fukunaga

Part of Trans Genic Inc., Primmune Inc is a Japanese company that manufactures and markets pharmaceutical ingredients. The private company is based in Kobe, Japan. Primmune was acquired by Trans Genic Inc. on May 15, 2006 for $2.15 million.

New Drug Research Center Inc. engages in the research, development and support of medical products, medical equipment, and chemical substances. It performs drugs and food clinical trials and tests compatible with good clinical practice (GCP). The company was founded in April 2013 and is headquartered in Tokyo, Japan.

TG Business Service Inc. engages in business succession, advise and support services relating to rehabilitation, and merger and acquisitions. The company was founded on November 15, 2017 and is headquartered in Fukuoka, Japan.

Part of Trans Genic Inc., Biosafety Research Center, Inc. is a safety test contractor that supports pharmaceuticals and food development. The private company is based in Iwata, Japan. The Japanese company is entrusted with clinical tests in animal species that are commonly used and analysis of subject substances and biological components in biological samples. The company offers physical properties analysis, spectrum measurement of the sample, water, ash, and content analysis. The company has developed several mouse models for stress visualization and gene visualization of oxidative stress. The company also conducts reproductive toxicity tests to examine the effects of subject substances on the reproductive function of the parent generation and the occurrence of the next generation.

Galax Corp. imports, wholesales, and retails porcelain, china, silverware, crystalware, kitchen items, and household goods. The company was founded on September 12, 1984 and is headquartered in Tokyo, Japan.

GeneticLab Co., Ltd. provides gene expression analysis and pathological diagnostic services. It also engages in medical care development services. The company was founded on September 1, 2000 and is headquartered in Sapporo, Japan.